Terms: = Pancreatic cancer AND MAF, MGC71685, 4094, ENSG00000178573 AND Prognosis
5 results:
1. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.
Amintas S; Fernandez B; Chauvet A; Chiche L; Laurent C; Belleannée G; Marty M; Buscail E; Dabernat S
Sci Rep; 2022 Feb; 12(1):2976. PubMed ID: 35194118
[TBL] [Abstract] [Full Text] [Related]
2. Targeted Transcriptome and
Lundy J; Gao H; Berry W; Masoumi-Moghoddam S; Jenkins BJ; Croagh D
Clin Cancer Res; 2021 Nov; 27(21):5900-5911. PubMed ID: 34400416
[TBL] [Abstract] [Full Text] [Related]
3. SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
Arqueros C; Salazar J; Arranz MJ; Sebio A; Mora J; Sullivan I; Tobeña M; Martín-Richard M; Barnadas A; Baiget M; Páez D
Med Oncol; 2017 Aug; 34(8):136. PubMed ID: 28687963
[TBL] [Abstract] [Full Text] [Related]
4. Plasma Circulating Tumor DNA in pancreatic cancer Patients Is a Prognostic Marker.
Pietrasz D; Pécuchet N; Garlan F; Didelot A; Dubreuil O; Doat S; Imbert-Bismut F; Karoui M; Vaillant JC; Taly V; Laurent-Puig P; Bachet JB
Clin Cancer Res; 2017 Jan; 23(1):116-123. PubMed ID: 27993964
[TBL] [Abstract] [Full Text] [Related]
5. pancreatic carcinogenesis: apoptosis and angiogenesis.
Onizuka S; Kawakami S; Taniguchi K; Fujioka H; Miyashita K
Pancreas; 2004 Apr; 28(3):317-9. PubMed ID: 15084979
[TBL] [Abstract] [Full Text] [Related]